Zurletrectinib

Modify Date: 2024-01-21 19:21:54

Zurletrectinib structure	Common Name	Zurletrectinib
	CAS Number	2403703-30-8	Molecular Weight	415.40
	Density	N/A	Boiling Point	N/A
	Molecular Formula	C₁₉H₁₉F₂N₇O₂	Melting Point	N/A
	MSDS	N/A	Flash Point	N/A

Use of Zurletrectinib

Zurletrectinib is a potent tyrosine kinase inhibitor. Zurletrectinib serves as an antineoplastic agent. Zurletrectinib can used for research of preventing TRK-mediated related diseases, such as tumors[1][2].

Name	Zurletrectinib

Description	Zurletrectinib is a potent tyrosine kinase inhibitor. Zurletrectinib serves as an antineoplastic agent. Zurletrectinib can used for research of preventing TRK-mediated related diseases, such as tumors[1][2].
Related Catalog	Research Areas >> Cancer Signaling Pathways >> Protein Tyrosine Kinase/RTK >> c-Met/HGFR
References	[1]. Kong NX, et al. Preparation of the heterocyclic compounds as trk inhibitor: World Intellectual Property Organization, WO2020001415. 2020-01-02. [2]. WHO Drug Information-World Health Organization (WHO).

Description

Related Catalog

Research Areas >> Cancer

Signaling Pathways >> Protein Tyrosine Kinase/RTK >> c-Met/HGFR

References

[1]. Kong NX, et al. Preparation of the heterocyclic compounds as trk inhibitor: World Intellectual Property Organization, WO2020001415. 2020-01-02.

[2]. WHO Drug Information-World Health Organization (WHO).

Molecular Formula	C₁₉H₁₉F₂N₇O₂
Molecular Weight	415.40

Zurletrectinib

Use of Zurletrectinib

Names

Zurletrectinib Biological Activity

Chemical & Physical Properties